Претрага
Резултати
Phase Ib study combining ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in patients with CD20-positive B-cell non-Hodgkin lymphoma (NHL) [2013]
Younes, Anas; ...; Todorovic, Marija; ...; (broj, koautora 16)HERIZON: A phase 1B/2 open-label study of imu-131 HER2/neu peptide vaccine PLUS standard of care chemotherapy with randomization in phase 2 in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal j [2021]
Laeufle, Rita; ...; Andric, Zoran GEMRseq: Registry-based outcome analysis on 1,000 patients with BRAF V600-mutated metastatic melanoma in Europe treated with either immune checkpoint or BRAF-/MEK inhibition. [2022]
Weichenthal, Michael; ...; Kandolf-Sekulovic, Lidija O; ...; (broj, koautora 20)Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma and methylated O-6-methylguanine-DNA methyltransferase (MGMT) gene promoter: Key results of the multicenter, randomized, open-label, controlled, phase III CENTRIC [2013]
Stupp, Roger; ...; Grujicic, Danica M; ...; (broj, koautora 20)The differences in rate and duration of complete remission between HER2-positive and HER2-negative inflammatory breast carcinoma [2009]
Kolarevic, Daniela; Tomasevic, Zorica IA phase IIa study of light-activated talaporfin sodium in patients with primary or recurrent glioblastoma multiforme [2009]
Keltner, L; Chen, JC; Wang, S; Rakic, Miodrag LPreoperative radiation (Preop RT) in rectal cancer additional chemotherapy - effect and timing of (CT) 5-year results of the EORTC 22921 trial [2005]
Bosset, J. F.; Calais, G.; Mineur, L.; Maingon, P.; Radošević-Jelić, LjiljanaCetuximab weekly (q1w) versus every two weeks (q2w) plus FOLFOX4 as first-line therapy in patients (pts) with KRAS wild-type (wt) metastatic colorectal cancer (mCRC) [2011]
Nikolić, VladimirRESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer [2024]
Spigel, David R; ...; Stojanovic, Goran; ...; Andric, Zoran GCharacteristics of HER2 3+ metastatic breast cancer patients with long-term benefit of trastuzumab.
[2017]
Tomašević, Zorica I. Филтери
По типу
- 156